Wed, Mar 29, 2017 | updated 02:46 PM IST

CSIR launches Ayurvedic Anti-diabetic Drug BGR-34

Updated: Jul 30, 2016 16:25 IST

New Delhi, July 30 (ANI-BusinessWireIndia): Council for Scientific and Industrial Research (CSIR) announced launch of BGR-34 - country's first anti-diabetic ayurvedic drug with DPP4 inhibitory Activity.

BGR-34, designed for type 2 Diabetes mellitus has been scientifically validated for its efficacy and safety. BGR-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the research units of CSIR, Govt. of India situated at Lucknow.

Passing its larger benefits to people, BGR-34 has been economically priced at Rs. five per tablet as compared to latest DPP4 inhibitors globally. BGR-34 is now available on all major chemist counter of Rajasthan.

"Six crore of the adult Indian population has been found to be diabetic and there is no effective solution for diabetes as yet. We are sure that eminent medical professionals will recommend it to their patients suffering from type II Diabetes mellitus for quicker and consistent response. CSIR's premier research institutions have developed and established the efficacy of BGR-34.

The modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs," said Sr. Principal Scientist of CSIR-NBRI, Dr. A.K.S. Rawat.

The scientists of NBRI and CIMAP, joined hands in developing an effective, safe, patient friendly solution towards management of type II Diabetes mellitus. They had in-depth study of over 500 renowned ancient herbs and finally identified the six best herbs listed in Ayurvedic ancient texts for various ailments and indications namely Daruharidra (Berberis aristata), Giloy (Tinospora cordifolia), Vijaysar (Pterocarpus marsupium), Gudmar (Gymnema Sylvestre), Majeeth (Rubia cordifoila) and Methika (Trigonella foenum-graecum) to be combined in different fractions and quantity and processed meticulously to develop a marvelous anti-diabetic formulation.

The herbs were further subjected to optimization studies to establish the right proportion.

Dr Daya Nandan Mani, Senior Scientist of CSIR-NBRI, said, "Pre-clinical studies of this antidiabetic formulation revealed significant reduction in high blood sugar level in diabetes induced experimental subjects, with the activity being comparable with the reference standard anti-diabetic allopathic drug." Besides, the drug was found to improve LFTs, KFT's and lipid profile significantly. It also provided the much needed pronounced antioxidant protective activity. No untoward effects were observed during the course of study. Clinical studies with BGR-34 have also revealed significant anti-diabetic activities with no untoward effects observed."

Pankaj Marwaha, Marketing Director of AIMIL Pharmaceuticals (India) Ltd, said, "We have decided to launch the ayurvedic anti-diabetic product in the brand name BGR-34 standing for Blood Glucose Regulator with 34 identified active phyto-constitutents from herbal resources. We want to pass on its benefits to the suffering people at a very low price. With a strong marketing distribution network spread all over the country, Aimil is strongly committed to carry forward the marvelous benefits of this novel research to the masses who are suffering all throughout the country and abroad."

For the purpose of quality commercial production and extended distribution, Aimil Pharmaceuticals (India) Ltd, the organization well known for its innovative, quality Herbal / Ayurvedic products, has been transferred the rights and technical knowhow to produce and market it for medical use.

The company is manufacturing BGR-34 at its state of the art manufacturing units, which are well equipped with latest technology for manufacturing quality medicines with astringent most quality control measures.

Dr Anil Kumar Sharma Vice President (Technical) of AIMIL Pharmaceuticals (India) Ltd, said, "BGR-34 is a unique product that manages the lives of human suffering diabetics. One of the critical ingredients inhibits DPP-4 and enhances insulin secretion. The product passed several battery of tests and showed hypoglycaemic activity in experimental subjects."

Aimil Pharmaceuticals already had one successful technological collaboration with DRDO (Defence Research and Development Organization, Govt. of India) yet another premier research institute in the country, for effective and safe treatment of leucoderma, still considered to be a big challenge to address.

The product for leucoderma was successfully launched in the market in the name Lukoskin, bringing smiles for the patient suffering from the social stigma, leucoderma.

In appreciation to its research work and commitment to develop high quality innovative drugs, Aimil Pharmaceuticals has been bestowed with three national awards from Govt. of India for manufacturing herbal medicines of outstanding quality and also for research and development activities.

Within a span of eight months of formal launch of BGR-34 from CSIR-NBRI on CSIR day, the company has produced and made available about 15 crore of tablets in the services of masses through a team of about 1000 medical representatives serving the eminent doctors in society. (ANI-BusinessWireIndia)

New Delhi [India], Mar. 29 (ANI): After an Aadhaar volunteer's "fan moment" after he prepared cricketer M.S. Dhoni's Aadhar card has become awkward for the government, Union Information and Technology Minister Ravi Shankar Prasad on Wednesday said Aadhar is fully safe.

Full Story >>

New Delhi [India], Mar. 29 (ANI): With the Municipal Corporation of Delhi (MCD) polls just around the corner, the Congress Party on Wednesday constituted a screening committee for the elections.

Full Story >>

New Delhi [India], Mar. 29 (ANI): Congress MP Veerappa Moily on Wednesday alleged that the anti-profiteering clause of the Goods and Services Tax (GST) Bill is excessively harsh and severe and should not be taken lightly.

Full Story >>

IMD forecasts rise in temperature till May

Updated: Mar 29, 2017 14:20 IST

New Delhi [India], Mar. 29 (ANI): The Indian Meteorology Department of Delhi (IMD) on Wednesday forecasted that Delhi has not witnessed heat-wave condition but the temperature in the national capital might increase till the month of May which is currently 37 degree, five degree more than what it should be.

Full Story >>

Adityanath moves into his official residence

Updated: Mar 29, 2017 13:57 IST

Lucknow (Uttar Pradesh) [India], Mar. 29 (ANI): Uttar Pradesh Chief Minister Yogi Adityanath on Wednesday moved into his official residence at 5, Kalidas Marg in Lucknow.

Full Story >>

New Delhi [India], Mar. 29 (ANI): Shiv Sena MP Anandrao Adsul on Wednesday moved a notice on his colleague Ravindra Gaikwad's issue in Lok Sabha, who was barred from travelling from any flight after he hit an Air India staffer with his slipper over an argument of sitting arrangement.

Full Story >>

New Delhi [India], Mar. 29 (ANI): The Supreme Court will continue hearing the arguments on the Bulandshahr gang rape case on April 20.

Full Story >>

African woman slapped in Noida

Updated: Mar 29, 2017 13:31 IST

Greater Noida (Uttar Pradesh) [India], Mar. 29 (ANI): Three days after four Nigerian nationals were attacked, an African woman has been allegedly thrashed in Greater Noida.

Full Story >>

New Delhi [India], Mar. 29 (ANI): Alleging that the youth of Kashmir have been provoked by Pakistan's terrorism, Minister of State (Mos) for Home Hansraj Ahir on Wednesday said India will not allow any violence to spread in the valley.

Full Story >>

Act against anything illegal: Baba Ramdev

Updated: Mar 29, 2017 12:40 IST

Lucknow (Uttar Pradesh) [India], Mar. 29 (ANI): Yoga Guru Baba Ramdev on Wednesday praised the Uttar Pradesh Government for its decision to close all illegal slaughter house.

Full Story >>

New Delhi [India], Mar. 29 (ANI): Union Finance Minister Arun Jaitley on Wednesday moved the four Goods and Services Tax (GST) Bill in the Lok Sabha for consideration.

Full Story >>

Srinagar/New Delhi [India], Mar. 29 (ANI): Condemning the recent Budgam encounter, the National Panthers Party (NPP) on Wednesday criticised Jammu and Kashmir Chief Minister Mehbooba Mufti and ¬said imposing Governor rule appears to be the only option before the administration.

Full Story >>

New Delhi [India], Mar. 29 (ANI): The National Green Tribunal (NGT) on Wednesday adjourned the Ganga cleaning matter for tomorrow.

Full Story >>

Centre says no proposal to enhance MPLAD fund

Updated: Mar 29, 2017 12:16 IST

New Delhi [India], Mar.29 (ANI): The Centre has no plans to increase the component of MPLAD fund, Minister of Statistics and Programme Implementation D.V.Sadananda Gowda told Shimla Member of Parliament Virender Kashyap recently.

Full Story >>

Mumbai (Maharashtra) [India], Mar. 29 (ANI): A special NIA court in Mumbai on Wednesday adjourned the hearing on framing charges against ISIS suspect Arib Majeed till April 13.

Full Story >>

Patna (Bihar) [India], Mar. 29 (ANI): Dubbing the reports that Bihar Chief Minister Nitish Kumar may join hands with the NDA as 'impossible and baseless', the Janata Dal (United) on Wednesday said their alliance is strong and is working for Bihar's development.

Full Story >>

New Delhi [India], Mar. 29 (ANI): A 19-year-old Indian Institute of Technology (IIT) student from Ranchi attempted to commit suicide in wee hours of Wednesday morning by jumping from his hostel premises.

Full Story >>

Anand (Gujarat) [India], Mar. 29 (ANI): A case has been registered against the director of Institute of Rural Management Anand (IRMA) after a professor complained of sexual harassment.

Full Story >>

Bengaluru (Karnataka) [India], Mar. 29 (ANI): A day after Karnataka house panel decided to form rules for media, the Bharatiya Janata Party (BJP) on Wednesday said regulating media is not healthy in a democratic setup and requested the Assembly Speaker to relook into his decision.

Full Story >>

New Delhi [India], Mar. 29 (ANI): The Delhi High Court on Wednesday dismissed the plea of Yogendra Yadav-led Swaraj India challenging the Election Commission's decision to not allot the common symbol to contest upcoming municipal corporations elections.

Full Story >>